What type of medication is montelukast categorized as?

What type of medication is montelukast categorized as?

• A. Cholinergic antagonist
• B. Short-acting beta2 agonist
• C. Leukotriene modifier
• D. Monoclonal antibody

Answer: (C)

Montelukast is classified as a leukotriene modifier. This category of medication works primarily by blocking the action of leukotrienes, which are inflammatory chemicals the body releases in response to allergens and respiratory irritants. By inhibiting these chemicals, montelukast helps reduce inflammation in the airways, thereby improving breathing and alleviating symptoms associated with conditions such as asthma and allergic rhinitis. This mechanism makes montelukast particularly beneficial for patients with asthma, as it can help control chronic symptoms and prevent exercise-induced bronchoconstriction. It is distinct from other types of medications used in respiratory conditions, such as short-acting beta2 agonists, which act quickly to relieve acute symptoms by relaxing bronchial smooth muscle, or monoclonal antibodies, which specifically target certain pathways in the immune response. Thus, montelukast's role as a leukotriene modifier is pivotal in managing asthma and allergies effectively.

Montelukast is classified as a leukotriene modifier. This category of medication works primarily by blocking the action of leukotrienes, which are inflammatory chemicals the body releases in response to allergens and respiratory irritants. By inhibiting these chemicals, montelukast helps reduce inflammation in the airways, thereby improving breathing and alleviating symptoms associated with conditions such as asthma and allergic rhinitis.

This mechanism makes montelukast particularly beneficial for patients with asthma, as it can help control chronic symptoms and prevent exercise-induced bronchoconstriction. It is distinct from other types of medications used in respiratory conditions, such as short-acting beta2 agonists, which act quickly to relieve acute symptoms by relaxing bronchial smooth muscle, or monoclonal antibodies, which specifically target certain pathways in the immune response. Thus, montelukast's role as a leukotriene modifier is pivotal in managing asthma and allergies effectively.